VCNX
Vaccinex Inc

5,650
Loading...
Loading...
News
all
press releases
Vaccinex Stock Spikes On 'Promising' Data On Alzheimer’s Drug Study: Retail Sentiment Brightens
The Rochester, N.Y.-based firm said it will present ‘promising’ new efficacy and safety data for the treatment of Alzheimer’s disease later this month.
Stocktwits·11mo ago
News Placeholder
More News
News Placeholder
What's Going On With Vaccinex Stock Wednesday?
Vaccinex shares are trading lower on Wednesday after the company announced $6.2 million in proceeds from the exercise of warrants as well as the issuance of new warrants for common stock. read more...
Benzinga·1y ago
News Placeholder
Vaccinex Reports 2023 Financial Results and Provides Corporate Update
Expect Topline Data for Phase 1/2a Randomized SIGNAL-AD Study of Pepinemab for Alzheimer's Disease in Q3 2024 Company raised $17.9 million of new financing during Q4 2023 and Q1 2024 ROCHESTER...
Globe Newswire·1y ago
News Placeholder
Vaccinex, Inc. (NASDAQ:VCNX) Sees Significant Decrease in Short Interest
Vaccinex, Inc. (NASDAQ:VCNX - Get Free Report) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 8,800 shares, a decline of 40.5% from the...
Zolmax·1y ago
News Placeholder
Vaccinex to raise $1.5M through in a direct offering
Vaccinex to raise $1.5M through in a direct offering...
SeekingAlpha.com: All News·1y ago
News Placeholder
Vaccinex prices 193,000 shares at $7.77 in registered direct offering
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
ROCHESTER, N.Y., March 27, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) ( Vaccinex or the Company ), a clinical-stage biotechnology company pioneering a differentiated approach to...
Globe Newswire·1y ago
News Placeholder
12 acciones de salud en movimiento durante la preapertura del 26/02/2024
Acciones al alza ZyVersa Therapeutics (NASDAQ:ZVSA) avanzaron un 47,31% para establecerse en los 1,18 d lares durante la sesi n del pre-market del lunes. Vaccinex (NASDAQ:VCNX) crecieron un 43,64...
Benzinga·2y ago
News Placeholder
Vaccinex Announces Multiple New Agreements for Access to ActivMAb Antigen Virus Technology
Eight new antibody discovery agreements incorporate Vaccinex's powerful ActivMAb Drug Discovery Platform ActivMab platform enables the discovery and development of high value antibodies against...
Globe Newswire·2y ago
News Placeholder
Vaccinex trading halted, news pending
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago

Latest VCNX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.